• Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech Potentially Undervalued Companies
1,975 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

TAK N

Takeda Pharmaceutical
JP¥240.490%-20.9%JP¥6.4tJP¥281.08PE36xE18.8%4.6%

8EQ

Cytek Biosciences
US$5.15n/a-47.2%US$756.1mUS$8.94PS3.9xE87.9%n/a

SUPRIYA

Supriya Lifescience
₹411.055.2%89.6%₹33.1b₹401.00PE27.5xE21.6%0.1%

3347

Hangzhou Tigermed Consulting
CN¥34.3016.5%-47.3%CN¥48.2bCN¥41.98PE30.5xE19.5%1.0%

2390

Guizhou Xinbang Pharmaceutical
CN¥3.924.8%-19.5%CN¥7.5bn/aPE26xn/a1.5%

0HIY

Atara Biotherapeutics
US$0.702.4%-74.6%US$83.1mUS$4.24PS9.7xE49.0%n/a

7XP

Organon
US$17.252.4%-22.6%US$4.8bUS$20.22PE4.7xE3.8%6.0%

1HB

Scorpius Holdings
US$0.115.6%-81.2%US$6.1mUS$6.69PB0.2xE44.7%n/a

300702

Zhejiang Tianyu Pharmaceutical
CN¥18.455.9%-34.6%CN¥6.4bCN¥22.60PS2.6xE91.9%0%

B9A

BioArctic
kr16.65-1.1%-27.0%kr17.4bkr30.87PE76.1xE48.2%0%

6XC

Soleno Therapeutics
US$34.16-1.2%1,086.1%US$1.3bUS$58.00PB8xE60.3%n/a

300841

Chengdu Kanghua Biological Products
CN¥63.008.6%-27.0%CN¥8.4bCN¥102.01PE15.1xE16.2%3.2%

8JM

Vetoquinol
€97.602.7%12.6%€1.2b€106.24PE21.2xE5.0%0.9%

GLS

Glenmark Life Sciences
₹819.20-2.4%62.4%₹100.4b₹905.75PE21.3xE13.1%2.7%

VW5

Cannabist Company Holdings
US$0.24-11.9%-43.5%US$119.2mn/aPB1.8xE97.9%n/a

AARTIDRUGS

Aarti Drugs
₹507.052.8%20.5%₹46.7b₹560.95PE25.9xE28.2%0.2%

BM8

BioMarin Pharmaceutical
US$76.62-8.0%-8.4%US$15.4bUS$104.13PE74.8xE29.6%n/a

0A3M

BioNTech
US$87.18-1.5%-23.9%US$21.0bUS$114.03PE21.1xE-20.2%n/a

1228

CANbridge Pharmaceuticals
HK$0.4129.7%-78.0%HK$176.3mHK$7.00PS1.6xE10.4%n/a

BIOCON

Biocon
₹306.1512.9%31.6%₹365.5b₹279.11PE30.5xE8.7%0.5%

9995

RemeGen
HK$27.85-1.8%-39.2%HK$26.8bHK$42.87PS11.1xE54.9%n/a

A28A

Affimed
US$4.49-5.9%-45.2%US$76.6mUS$20.15PS5.1xE3.9%n/a

600993

Mayinglong Pharmaceutical Group
CN¥27.16-3.6%3.8%CN¥11.7bn/aPE25.8xn/a1.5%

600079

Humanwell Healthcare (Group)Ltd
CN¥21.196.3%-21.5%CN¥34.1bn/aPE16xE14.3%2.2%
Page 80 of 83
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.